Leif Gunnar Håkansson
Algemeen Directeur bij CanImGuide Therapeutics AB
Actieve functies van Leif Gunnar Håkansson
| Bedrijven | Functie | Begin | Einde |
|---|---|---|---|
CanImGuide Therapeutics AB
 CanImGuide Therapeutics AB Pharmaceuticals: MajorHealth Technology CanImGuide Therapeutics AB develops cancer therapies. The firm is a biotechnological company that reverses cancer related immunosuppression. It manufactures the proprietary drug P28R, a peptide with two modes of actions. The company was founded on March 21, 2006 and is headquartered in Hollviken, Sweden. | Directeur/Bestuurslid | - | - |
| Algemeen Directeur | - | - | |
| Hoofd Techniek/Wetenschap/O&O | - | - | |
| Oprichter | - | - |
Loopbaan van Leif Gunnar Håkansson
Eerdere bekende functies van Leif Gunnar Håkansson
| Bedrijven | Functie | Begin | Einde |
|---|---|---|---|
University of Linköping
 University of Linköping Other Consumer ServicesConsumer Services Linköping University Hospital provides healthcare services. | Corporate Officer/Principal | - | - |
| University of Lund | Corporate Officer/Principal | - | - |
Opleiding van Leif Gunnar Håkansson
| University of Lund | Doctorate Degree |
Statistieken
Internationaal
| Zweden | 4 |
Operationeel
| Corporate Officer/Principal | 2 |
| Director/Board Member | 1 |
| Chief Executive Officer | 1 |
Sectoraal
| Consumer Services | 3 |
| Health Technology | 2 |
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Verwante bedrijven
| Bedrijven in privébezit | 1 |
|---|---|
CanImGuide Therapeutics AB
CanImGuide Therapeutics AB Pharmaceuticals: MajorHealth Technology CanImGuide Therapeutics AB develops cancer therapies. The firm is a biotechnological company that reverses cancer related immunosuppression. It manufactures the proprietary drug P28R, a peptide with two modes of actions. The company was founded on March 21, 2006 and is headquartered in Hollviken, Sweden. | Health Technology |
